1. Home
  2. NKGN vs MULN Comparison

NKGN vs MULN Comparison

Compare NKGN & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • MULN
  • Stock Information
  • Founded
  • NKGN 2017
  • MULN 2014
  • Country
  • NKGN United States
  • MULN United States
  • Employees
  • NKGN N/A
  • MULN N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • MULN Auto Manufacturing
  • Sector
  • NKGN Health Care
  • MULN Consumer Discretionary
  • Exchange
  • NKGN Nasdaq
  • MULN Nasdaq
  • Market Cap
  • NKGN 24.1M
  • MULN 32.6M
  • IPO Year
  • NKGN N/A
  • MULN N/A
  • Fundamental
  • Price
  • NKGN $1.16
  • MULN $1.30
  • Analyst Decision
  • NKGN
  • MULN
  • Analyst Count
  • NKGN 0
  • MULN 0
  • Target Price
  • NKGN N/A
  • MULN N/A
  • AVG Volume (30 Days)
  • NKGN 2.3M
  • MULN 2.1M
  • Earning Date
  • NKGN 08-16-2024
  • MULN 08-12-2024
  • Dividend Yield
  • NKGN N/A
  • MULN N/A
  • EPS Growth
  • NKGN N/A
  • MULN N/A
  • EPS
  • NKGN N/A
  • MULN 2821.15
  • Revenue
  • NKGN N/A
  • MULN $399,335.00
  • Revenue This Year
  • NKGN N/A
  • MULN N/A
  • Revenue Next Year
  • NKGN N/A
  • MULN N/A
  • P/E Ratio
  • NKGN N/A
  • MULN $0.00
  • Revenue Growth
  • NKGN N/A
  • MULN N/A
  • 52 Week Low
  • NKGN $0.78
  • MULN $1.34
  • 52 Week High
  • NKGN $6.70
  • MULN $153.00
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 50.27
  • MULN 17.65
  • Support Level
  • NKGN $1.12
  • MULN $2.15
  • Resistance Level
  • NKGN $1.36
  • MULN $2.20
  • Average True Range (ATR)
  • NKGN 0.15
  • MULN 0.14
  • MACD
  • NKGN 0.02
  • MULN -0.03
  • Stochastic Oscillator
  • NKGN 65.67
  • MULN 0.45

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About MULN Mullen Automotive Inc.

Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.

Share on Social Networks: